Back to trial details

Intake questionnaire

Phase 3 Study of Gedatolisib as First-Line Treatment for Patients With HR-Positive, HER2-Negative Advanced Breast Cancer (VIKTORIA-2)

Applying to Rittenhouse Hematology/Oncology · Philadelphia, Pennsylvania

Answer a few short questions to share with the research team.

0 of 4 answered

1. Are you 18 years old or older?
2. Have you been diagnosed with Breast Cancer?
3. Are you currently pregnant or breastfeeding?
4. Are you able to travel to Philadelphia for study visits?